… to the diagnostic, therapeutic, and preventive aspects of nonalcoholic fatty liver disease (…
by the American Association for the Study of Liver Diseases (AASLD) and is an update to …

The increasing knowledge on the mechanisms responsible for hepatic fibrogenesis together
with the introduction of potentially more effective therapeutic strategies for chronic liver …

… Portal hypertension can be an early event in chronic cholestatic liver disease, sometimes …
cause and may delay liver disease progression; only liver transplant is potentially curative. …

Guidelines; 1 (3) guideline policies of the three societies approving this document; and (4) the
experience of the authors and independent reviewers with regards to NAFLD. Intended for …

… When patients with unsuspected hepatic steatosis detected on imaging have symptoms
or signs attributable to liver disease or have abnormal liver biochemistries, they should be …

… ) on the management of cholestatic liver diseases define the use of diagnostic, therapeutic
… procedures, in the management of patients with cholestatic liver diseases. They are intended …

… No single laboratory test is diagnostic for nonalcoholic fatty liver disease. Liver enzyme
levels have low sensitivity and specificity, and do not predict clinical outcomes. Although …

… pharmacological antihyperglycemic therapies with an emphasis on liver disease-related
clinical outcomes. Finally, we proposed an algorithm for managing DM in patients with CLD and …

… -filled cysts in the liver. PLD is part of the spectrum of fibrocystic liver diseases, which all involve
the … : isolated polycystic liver disease (PCLD) and autosomal dominant polycystic kidney …

… other causes of fatty liver disease such as alcohol. The disease is heterogeneous and develops
… liver disease that may necessitate liver transplantation to save the patient’s life (figure 1). …